Alto Neuroscience Statistics
Total Valuation
ANRO has a market cap or net worth of $854.94 million. The enterprise value is $718.18 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ANRO has 35.05 million shares outstanding. The number of shares has increased by 17.28% in one year.
| Current Share Class | 35.05M |
| Shares Outstanding | 35.05M |
| Shares Change (YoY) | +17.28% |
| Shares Change (QoQ) | +26.12% |
| Owned by Insiders (%) | 3.79% |
| Owned by Institutions (%) | 38.05% |
| Float | 23.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 5.13 |
| P/TBV Ratio | 5.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.69, with a Debt / Equity ratio of 0.16.
| Current Ratio | 15.69 |
| Quick Ratio | 15.58 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -26.88 |
Financial Efficiency
Return on equity (ROE) is -41.80% and return on invested capital (ROIC) is -24.15%.
| Return on Equity (ROE) | -41.80% |
| Return on Assets (ROA) | -22.90% |
| Return on Invested Capital (ROIC) | -24.15% |
| Return on Capital Employed (ROCE) | -38.28% |
| Weighted Average Cost of Capital (WACC) | 15.37% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$929,971 |
| Employee Count | 68 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +937.87% in the last 52 weeks. The beta is 2.06, so ANRO's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | +937.87% |
| 50-Day Moving Average | 22.14 |
| 200-Day Moving Average | 12.98 |
| Relative Strength Index (RSI) | 52.20 |
| Average Volume (20 Days) | 347,541 |
Short Selling Information
The latest short interest is 2.19 million, so 6.25% of the outstanding shares have been sold short.
| Short Interest | 2.19M |
| Short Previous Month | 1.98M |
| Short % of Shares Out | 6.25% |
| Short % of Float | 9.16% |
| Short Ratio (days to cover) | 5.66 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -66.36M |
| Pretax Income | -63.24M |
| Net Income | -63.24M |
| EBITDA | -65.70M |
| EBIT | -66.36M |
| Earnings Per Share (EPS) | -$2.19 |
Full Income Statement Balance Sheet
The company has $176.48 million in cash and $23.96 million in debt, giving a net cash position of $152.53 million or $4.35 per share.
| Cash & Cash Equivalents | 176.48M |
| Total Debt | 23.96M |
| Net Cash | 152.53M |
| Net Cash Per Share | $4.35 |
| Equity (Book Value) | 151.14M |
| Book Value Per Share | 4.73 |
| Working Capital | 166.39M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$51.77 million and capital expenditures -$24,000, giving a free cash flow of -$51.79 million.
| Operating Cash Flow | -51.77M |
| Capital Expenditures | -24,000 |
| Depreciation & Amortization | 661,000 |
| Net Borrowing | 10.23M |
| Free Cash Flow | -51.79M |
| FCF Per Share | -$1.48 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |